Emporia Hospital Corporation
Emporia Hospital Corporation was paid $1.73M by Medicaid between Jan 2018 and Dec 2019, across 84 billing codes. Its largest line is 99283, emergency room visit (moderate) — 35% of everything it billed.
EMPORIA, VA 23847
Next to other General Acute Care Hospital providers in Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,327 | $702K | |
| 2019 | 43,322 | $1.03M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 7,756 | 6,318 | $604K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 2,998 | 2,365 | $224K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.7% | 1,627 | 1,415 | $115K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.8% | 1,252 | 1,138 | $101K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.8% | 3,037 | 684 | $100K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.6% | 970 | 724 | $98K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.5% | 1,589 | 1,177 | $95K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.3% | 734 | 605 | $75K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.6% | 1,057 | 474 | $62K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3.3% | 1,578 | 980 | $58K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.1% | 373 | 294 | $54K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 5,868 | 3,834 | $21K |
72 more codes
| G0378 | Hospital observation service, per hour | <1% | 218 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 378 | $11K |
| 80053 | Comprehensive metabolic panel | <1% | 3,509 | $11K |
| 97161 | <1% | 444 | $8K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 37 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,042 | $6K |
| 86756 | <1% | 443 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 657 | $5K |
| 87430 | <1% | 1,235 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 16 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 696 | $4K |
| 81025 | <1% | 1,281 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,327 | $4K |
| J3490 | Unclassified drugs | <1% | 4,330 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 49 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,145 | $3K |
| 84484 | <1% | 2,068 | $3K | |
| 81001 | <1% | 3,440 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,924 | $2K |
| 83880 | <1% | 768 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 559 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,192 | $2K |
| 87040 | <1% | 293 | $2K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 14 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,451 | $1K |
| 73564 | <1% | 93 | $1K | |
| 82962 | <1% | 856 | $1K | |
| 83605 | <1% | 470 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,814 | $714.53 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,935 | $712.64 |
| 97016 | <1% | 68 | $687.32 | |
| 80320 | <1% | 200 | $587.34 | |
| 80061 | Lipid panel | <1% | 71 | $521.37 |
| 83735 | <1% | 1,184 | $496.70 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 934 | $437.89 |
| 73630 | <1% | 51 | $400.54 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 680 | $381.76 |
| 85610 | <1% | 1,324 | $335.13 | |
| 73130 | <1% | 41 | $306.45 | |
| 83874 | <1% | 92 | $248.68 | |
| 83690 | <1% | 643 | $242.33 | |
| 85730 | <1% | 1,216 | $229.71 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $220.88 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 18 | $215.02 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 492 | $192.75 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 173 | $181.60 |
| 85027 | <1% | 58 | $156.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 94 | $95.56 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 19 | $78.12 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 20 | $73.03 |
| 73610 | <1% | 17 | $57.42 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 342 | $30.89 |
| 82553 | <1% | 19 | $17.98 | |
| 82150 | <1% | 48 | $16.01 | |
| 84702 | <1% | 13 | $14.85 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 145 | $13.22 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 132 | $10.70 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $10.46 |
| 87186 | <1% | 38 | $9.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 111 | $9.36 |
| 87077 | <1% | 92 | $9.33 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 59 | $6.63 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 35 | $2.60 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 14 | $1.65 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 18 | $0.46 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 194 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 28 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 18 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 270 | $0.00 |
| 96376 | 0% | 73 | $0.00 | |
| 82550 | 0% | 41 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.